Another study published in JAMA Network Open found that patients taking Semaglutide achieved greater mean percent change in body weight compared with those taking a placebo (-5% vs -2%)
Clinical trial data show that while fat mass accounts for the majority of weight loss, some lean mass reduction also occurs, which could potentially affect muscle function
How is GHK-Cu administered
14,15 This may not be surprising, since private insurers can be reluctant to invest in prevention, 16,17 and the benefits of weight loss may not be fully realized until people transition to Medicare
For minimal disruption, consider a weekend morning injection, giving yourself more flexibility to rest or adjust your activities if mild side effects occur
Beyond this, Novo Nordisk and Eli Lilly have patents and lots and lots of lawyers, so it will be interesting to see how enduring a program like HIMS will be